Special Issue "Optimizing the Use of Technology in Oncology Care: Post Pandemic Opportunities"
Deadline for manuscript submissions: 31 July 2022 | Viewed by 147
2. Center for Excellence in Behavioral Medicine and Quality of Life Program for UPMC’s Liver Cancer Center, Pittsburgh, PA, USA
Interests: psycho-oncology; psychoneuroimmunology; interventions; caregiving; cancer; quality of life; health; behavioral medicine
While the use of technology in healthcare has increased dramatically in the last decade the SARS-CoV-2 pandemic expedited the use of technology in health care. While a minority of health care providers used technology prior to the pandemic, nearly all specialties, including oncology, utilized telemedicine or other forms of technology during the pandemic to improve access to care. Opportunities to optimize the use of technology in oncology have not yet been realized. For this Special Issue in Current Oncology, we encourage submissions focused on unique contributions that will facilitate the advancement of the field of oncology including novel uses of telemedicine in oncology; novel digital approaches, methods, or devices used in cancer care; evaluation of eHealth/mHealth interventions; the implementation or dissemination of mHealth, eHealth, or social media in research or care of those diagnosed with cancer; ecological momentary assessment, sensors, or mobile technologies used in oncology; effects of the internet, mHealth, eHealth or social media on patient-physician relationship or communication; ethical or legal issues associated with eHealth or mHealth in oncology including security and confidentiality; health disparities in the use of technology in oncology; use of electronic medical records or patient portals; telemonitoring or tele epidemiology in oncology; the use of technology in behavior change for the prevention of cancer; cybermetrics, digital imaging and multimedia in oncology; innovative or emerging technologies in oncology; the use of technology in the basic sciences in oncology; the technology in mentoring, education, and consulting in the field of oncology; and the use of technology in clinical trials or e-trials in oncology.
Dr. Jennifer Steel
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- behavior change
- patient portals
- health disparities
- clinical trials
- social media
- patient-physician communication
- digital imaging